Sanofi Blew Whistle On Mylan's EpiPen Rebate Woes: Feds

By Brian Amaral (August 17, 2017, 12:54 PM EDT) -- Mylan will pay $465 million to resolve allegations that it ripped off the government by underpaying rebates for the EpiPen, federal authorities said Thursday, revealing for the first time that competitor Sanofi first blew the whistle in a False Claims Act suit....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!